# Janssen Pharmaceuticals Inc. - Inspection Records

Source: https://www.keypedia.com/companies/janssen-pharmaceuticals-inc/b494dc6e-cfeb-46a2-8c10-e036e6a5a623

> Inspection records and compliance data for Janssen Pharmaceuticals Inc. in Raritan, New Jersey. Access full analysis and detailed observations.

---

## Details

- Name: Janssen Pharmaceuticals Inc.
- FEI Number: 2211100
- City: Raritan
- State: New Jersey
- Country Name: United States
- Address Line 1: 1000 U.S. Route 202 South
- Zip Code: 08869

## Related Documents

- [483 - Janssen Pharmaceuticals Inc. - Unknown Date](https://www.keypedia.com/records/483/janssen-pharmaceuticals-inc/82d909e3-7138-4083-bfb4-4a18fd99a0de) — source: FDA, date: Invalid Date
- [FDA Inspection 1252007 - Janssen Pharmaceuticals Inc. - 2024-11-01](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/6cf9b413-b5b9-41ea-a1db-605ee18bf2ee) — source: FDA, date: November 1, 2024
- [483 - Janssen Pharmaceuticals Inc. - 2023-12-14](https://www.keypedia.com/records/483/janssen-pharmaceuticals-inc/c421012f-38e2-4ef0-8f9f-cd8d3bea7155) — source: FDA, date: December 14, 2023
- [FDA Inspection 1225275 - Janssen Pharmaceuticals Inc. - 2023-12-14](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/f5eb5852-3f6a-4246-a387-cf35044c8d21) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 14, 2023
- [FDA Inspection 1175643 - Janssen Pharmaceuticals Inc. - 2022-06-17](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/96ba00a9-75a4-42fe-8c7e-317d1ee03074) — classification: No Action Indicated (NAI), source: FDA, date: June 17, 2022
- [FDA Inspection 998113 - Janssen Pharmaceuticals Inc. - 2017-01-26](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/b3ea6272-4a0c-4c2c-a92b-37b8191ae003) — classification: No Action Indicated (NAI), source: FDA, date: January 26, 2017
- [FDA Inspection 965139 - Janssen Pharmaceuticals Inc. - 2016-01-22](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/b3173e7d-2caa-4560-acd5-80f483d514bf) — classification: No Action Indicated (NAI), source: FDA, date: January 22, 2016
- [FDA Inspection 833775 - Janssen Pharmaceuticals Inc. - 2013-05-21](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/7142c62c-b7f3-4997-aa1a-ced0ebfb4d44) — classification: No Action Indicated (NAI), source: FDA, date: May 21, 2013
- [FDA Inspection 787093 - Janssen Pharmaceuticals Inc. - 2012-06-19](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/e08e9e62-12f5-45f9-a232-211fd3d1ef1e) — classification: No Action Indicated (NAI), source: FDA, date: June 19, 2012
- [FDA Inspection 740773 - Janssen Pharmaceuticals Inc. - 2011-08-22](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/5b9ce8ae-a048-4a9e-82c9-999a87ab542e) — classification: No Action Indicated (NAI), source: FDA, date: August 22, 2011
- [FDA Inspection 674432 - Janssen Pharmaceuticals Inc. - 2010-08-06](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/c8af46f0-19d5-4732-b17c-baedd973b8c5) — classification: No Action Indicated (NAI), source: FDA, date: August 6, 2010
- [FDA Inspection 556188 - Janssen Pharmaceuticals Inc. - 2009-01-15](https://www.keypedia.com/records/fda_inspections/janssen-pharmaceuticals-inc/782118ce-f578-4dbe-bf1e-eba48df227b5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 15, 2009

## Related Companies

- [Lyne Laboratories, Inc.](https://www.keypedia.com/companies/lyne-laboratories-inc/47a79cbe-dd2e-43d9-bf70-129caae3817c)
- [Finish Line Horse Products, Inc.](https://www.keypedia.com/companies/finish-line-horse-products-inc/205e6869-8995-4e35-9af4-e022b2dedb77)
- [Fareva Richmond, Inc.](https://www.keypedia.com/companies/fareva-richmond-inc/d42f54e3-2fe8-4501-b6ba-43cd66d2f5cb)
- [Amgen Technology (Ireland) Unlimited Company](https://www.keypedia.com/companies/amgen-technology-ireland-unlimited-company/576ab93b-ec8d-4b76-b25c-a1c473d6ae61)
- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f969afa9-62d8-4cde-8873-48180823df9b)
- [Catalent Pharma Solutions, LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/12f42026-6a34-4cfe-936d-3646a0e34c8d)
- [Glaukos Corporation](https://www.keypedia.com/companies/glaukos-corporation/9e9a7fd4-2158-4073-b5b9-79ba4fbdde83)
- [Viatris Pharmaceuticals LLC](https://www.keypedia.com/companies/viatris-pharmaceuticals-llc/b3d7bba7-bfc8-4d2b-a517-321f7b518a12)
- [Reckitt Benckiser Healthcare Manufacturing (Thailand) Ltd.](https://www.keypedia.com/companies/reckitt-benckiser-healthcare-manufacturing-thailand-ltd/016a0f4a-a4f3-47c7-8efa-58dc8165038d)
- [Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.](https://www.keypedia.com/companies/octapharma-pharmazeutika-produktionsgesellschaft-mbh/36184852-dad7-4350-8b6f-36d4527ba46f)

## Related Officers

- [Laurel A. Beer](https://www.keypedia.com/people/laurel-a-beer/0ac1e74f-0ff6-4db6-a0e8-0c3fb013720e)
- [Investigator](https://www.keypedia.com/people/thai-d-truong/7395c128-0adb-44a1-8831-64673c98e93d)
- [Lead Consumer Safety Officer](https://www.keypedia.com/people/xiuju-lu/90517f8a-e5ac-44a9-b2a2-3358e114754f)
- [Carl A. Perez](https://www.keypedia.com/people/carl-a-perez/a7214b90-7632-4aff-8afb-33f1d7e7917d)